A federal judge in Connecticut has declined to pause the multistate antitrust litigation accusing generic-drug manufacturers of price-fixing, even as settlement discussions continue. The decision keeps one of the most closely watched coordinated state enforcement actions on an active track, preserving litigation pressure while negotiations unfold in parallel.

The case is part of the long-running generic-drug pricing litigation brought by a coalition of state attorneys general against multiple manufacturers.

The U.S. Department of Justice’s Antitrust Division, joined by the Ohio Attorney General, has filed a civil antitrust suit against OhioHealth, alleging the health system used contracting practices that unlawfully restricted competition and increased healthcare costs. The case, United States of America et al v. OhioHealth Corporation, puts a spotlight on how enforcers are continuing to scrutinize not just mergers, but also the day-to-day terms health systems negotiate with commercial payers.

That distinction matters.

The antitrust challenge to Live Nation and Ticketmaster remains one of the most closely watched business cases in the country, even as reports indicate the U.S. Department of Justice reached a tentative settlement with the company in March 2026. The reason is straightforward: a broad coalition of states is still pressing forward, ensuring that the litigation continues to shape how courts, regulators, and the live-entertainment industry think about market power, vertical integration, and consumer harm.

The case, pending in the Southern District of New York as United States of America et al v. Live Nation Entertainment, Inc. et al, targets practices that have long drawn criticism from artists, venues, fans, and policymakers: ticketing fees, exclusive venue arrangements, and the combined influence that comes from operating both ticketing platforms and concert promotion businesses.

The Justice Department’s Antitrust Division has announced a federal grand jury indictment charging Jon Christopher Burt, Gerald Steven Lavender, and Jack Nelson Purvis Jr. in an alleged bid-rigging conspiracy involving sports equipment contracts for Mississippi public schools. The case is another reminder that criminal antitrust enforcement remains a live risk in public-procurement markets, including transactions that may appear routine or localized.

According to the DOJ’s announcement, the indictment centers on alleged collusion in the sale of sports equipment to school districts.

The Federal Trade Commission and the DOJ’s Antitrust Division have launched a joint public inquiry into the effectiveness of the Premerger Notification and Report Form, a notable step that signals possible changes to the Hart-Scott-Rodino merger filing process. Although this is not a challenge to any one transaction, it is the kind of regulatory move that can reshape day-to-day antitrust practice long before the next headline merger fight reaches court.

At a high level, the agencies are asking whether the current form gives them the information they need to evaluate deals efficiently and accurately.